British Thoracic Society guideline for non-CFbronchiectasis
- M C Pasteur1,
- D Bilton2,
- A T Hill3
- on behalf of the British Thoracic Society Bronchiectasis (non-CF) Guideline Group
- 1Norfolk and Norwich University Hospital, Norwich, UK
- 2Royal Brompton Hospital, London, UK
- 3Royal Infirmary of Edinburgh, Edinburgh, UK
- Correspondence to M C Pasteur, Norfolk and Norwich University Hospital, Colney Lane, Norwich NR4 7UY, UK; mark.pasteur{at}nnuh.nhs.uk
- Received 29 January 2010
- Accepted 16 February 2010
Abstract
The diagnosis, investigation and particularly management of bronchiectasis has been largely empirical and the subject of relatively few controlled clinical trials. There are no clear guidelines, although an Australian position statement has been published concerning bronchiectasis in children. The purposes of these guidelines were therefore threefold: (1) to identify relevant studies in non-cystic fibrosis (CF) bronchiectasis; (2) to provide guidelines on management based on published studies where possible or a consensus view; and (3) to identify gaps in our knowledge and identify areas for future study.
Footnotes
-
Competing interests DB has undertaken consultancy for Transave and Aradigm. MCP and ATH have no competing interests.
-
Provenance and peer review Not commissioned; not externally peer reviewed.
